Navigation Links
Research explores interactions between nanomaterials, biological systems
Date:6/19/2009

The recent explosion in the development of nanomaterials with enhanced performance characteristics for use in commercial and medical applications has increased the likelihood of people coming into direct contact with these materials.

There are currently more than 800 products on the market including clothes, skin lotions and cleaning products claiming to have at least one nanocomponent, and therapeutic nanocarriers have been designed for targeted drug delivery inside the human body. Human exposure to nanomaterials, which are smaller than one one-thousandth the diameter of a human hair, raises some important questions, including whether these "nano-bio" interactions could have adverse health effects.

Now, researchers at UCLA and the California NanoSystems Institute (CNSI), along with colleagues in academia and industry, have taken a proactive role in examining the current understanding of the nano-bio interface to identify the potential risks of engineered nanomaterials and to explore design methods that will lead to safer and more effective nanoparticles for use in a variety of treatments and products.

In a research review published in the July issue of the journal Nature Materials (and currently available online), the team provides a comprehensive overview of current knowledge on the physical and chemical properties of nanomaterials that allow them to undergo interactions with biological molecules and bioprocesses.

"What we have established here is a blueprint that will serve to educate the first generation of nanobiologists," said Dr. Andre Nel, leader of the team and chief of the division of nanomedicine at the David Geffen School of Medicine at UCLA and the California NanoSystems Institute.

Despite remarkable advances in nanoscience, relatively little is known about the intracellular activity and function of engineered nanomaterials, an area of study particularly important for the development of e
'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... - Bacteria possess an ingenious mechanism for pre... the cell. This is the new finding of a team of bi...e sciences research institute in Flanders, Belgium... scientists made this discovery by modifying the D... By means of this model organism, they have uncove...
(Date:11/20/2009)...Research Center (ERC) has been awarded a grant fro...ethods of recovering and reusing the heat that wou...ression process in a carbon capture system. The go... capture and sequestration, or storage (CCS), and ...emitted into the atmosphere by coal-fired power pl...
(Date:11/19/2009)...which cultivate fungus for food, have many remarka... list: the ant farmers, like their human counterpa...eir gardens grow. The finding, reported this week ...eviously unknown symbiosis between ants and bacter...have come to dominate the American tropics and sub...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Like humans, ants use bacteria to make their gardens grow 2FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 1FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 2FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 3GeoVax Labs Requests pre IND Meeting With FDA 14181 1GeoVax Labs Requests pre IND Meeting With FDA 14181 2GeoVax Labs Requests pre IND Meeting With FDA 14181 3Family Planning for the Worlds Poor 3A Who Will Pay 3F 57794 1Family Planning for the Worlds Poor 3A Who Will Pay 3F 57794 2
...iversity of Alaska Fairbanks neuroscientists study...resent their research findings at the 7th Conferen...ms in New York Aug. 19-22, 2008. , The scientists... at the UAF Institute of Arctic Biology, which is ...se goal is to expand and stimulate basic neuroscie...
... 2008 -- Elsevier, a leading global healthcare and...lists in The Elsevier Grand Challenge, a competiti...tools innovating how Life Sciences information is ...ts were chosen by a distinguished panel of judges ...nge of approaches involving semantics, visualizati...
...8, 2008 With oil prices skyrocketing, the search ...arch published this month in Agronomy Journal ex... Corn stover is made up of the leaves and stalks ...rvesting the edible corn grain. Corn stover could ...y 2030. , Scientists with the USDA-ARS Agroecosy...
Other Biology News:Stroke and SIDS in Alaska topics of neuroscience conference 2Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge 2Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge 3
(Date:11/19/2009)..., Nov. 19 Arlington Medical Resour...ding driver of antibiotic selection in nosocomial ...inst gram-positive and gram-negative pathogens. Du...omial pneumonia, surveyed European physicians reve...e appropriate coverage against common pathogens, p...
(Date:11/19/2009)...nd recognized refractive and cataract surgery expe...their fellow surgeons up-to-date on the latest dev...urgery, and ophthalmology in general at the recent...O) annual meeting in San Francisco, California. Dr... Huang, MD, Dr. Randy Epstein, Dr. William Trattle...
(Date:11/19/2009)...9 AFFiRiS AG will focus its,Alzhei...an unexpectedly early,stage of development: the va...e II clinical trial early in 2010. This decision b...f two Phase I trials with the candidates,AD01 and ...irst interim,analysis of the secondary endpoints a...
(Date:11/18/2009)...nd explosive materials and persons who have been i...ional Institute of Standards and Technology (NIST)...urity, has developed a new certified reference mat...ce Particulate Explosives. Compatible with field a...ul in calibrating, testing and developing standard...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New NIST trace explosives standard slated for homeland security duty 2
...l/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; TSX: A...,endocrine therapy and oncology, today reported th...y,s first efficacy trial of its Phase 3 program,in...us enlargement of the,prostate, with its flagship ...approximately 600 patients primarily in the United...
....,(SWX: ARPN) today announced that it will host a ...m CET. In this conference call, a leading expert w...he area of anti-infective,drugs as well as the out...gs Advisory Committee. During that meeting, the co... trial design for both mild/moderate and,moderate/...
...n Association for Cancer Research ...ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) announ...s,registrational bioequivalence clinical study of ...n Association for Cancer Research (AACR),Annual Me...kinetic,equivalence observed between an emulsion f...
Other Biology Technology:AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 3AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 4Arpida Announces Conference Call on 17 April 2Arpida Announces Conference Call on 17 April 3ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 2ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 3ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 4ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 5
Anti-p14ARF / p16Beta Ab-1 Polyclonal Antibody, Unconjugated from Lab Vision
Mouse Anti-Human MCAF-(MCP-1) Antibody, from Abazyme
Mouse Anti-Human Gastric Carcinoma Marker [BY-1] Monoclonal Antibody, Unconjugated, Clone 3H11 from Santa Cruz Biotechnology, Inc.
Goat Anti-LTBP-1 (E-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: